Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Alison Stopeck, Adam Brufsky, Lisa Kennedy, Sumi Bhatta, Debajyoti Bhowmik, Jacqueline Buchanan, Nicolas Despiegel & Guy Hechmati. (2020) Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States. Journal of Medical Economics 23:1, pages 37-47.
Read now
Read now
David Henry, Roger von Moos, Jean-Jacques Body, Alex Rider, Jonathan De Courcy, Debajyoti Bhowmik, Francesca Gatta, Guy Hechmati & Yi Qian. (2019) Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in the United States. Current Medical Research and Opinion 35:3, pages 375-381.
Read now
Read now
Debajyoti Bhowmik, Xue Song, Michele Intorcia, Stephani Gray & Nianwen Shi. (2019) Examination of burden of skeletal-related events in patients naive to denosumab and intravenous bisphosphonate therapy in bone metastases from solid tumors population. Current Medical Research and Opinion 35:3, pages 513-523.
Read now
Read now
Leah J McGrath, Robert A Overman, Diane Reams, Karynsa Cetin, Alexander Liede, Steven A Narod, M Alan Brookhart & Rohini K Hernandez. (2018) Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US. Clinical Epidemiology 10, pages 1349-1358.
Read now
Read now
Emily Nash Smyth, Ilaria Conti, James E. Wooldridge, Lee Bowman, Li Li, David R. Nelson & Daniel E. Ball. (2016) Frequency of skeletal-related events and associated healthcare resource use and costs in US patients with multiple myeloma. Journal of Medical Economics 19:5, pages 477-486.
Read now
Read now
Articles from other publishers (19)
Darcy R. Flora, Jennifer Schenfeld, Hossam Saad, Ben Cadieux, Guy Boike & Kimberly A. Lowe. (2023) Assessment of Bone Health Awareness and Education in Breast Cancer Patients with Bone Metastasis in the USA. Journal of Cancer Education.
Crossref
Crossref
Alberto Bazzocchi, Maria Pilar Aparisi Gómez, Makoto Taninokuchi Tomassoni, Alessandro Napoli, Dimitrios Filippiadis & Giuseppe Guglielmi. (2022) Musculoskeletal oncology and thermal ablation: the current and emerging role of interventional radiology. Skeletal Radiology 52:3, pages 447-459.
Crossref
Crossref
Takahiro Hirano, Naoko Saito, Ryozo Wakabayashi & Ryohei Kuwatsuru. (2023) Validation of Algorithms to Identify Bone Metastases Using Administrative Claims Data in a Japanese Hospital. Drugs - Real World Outcomes.
Crossref
Crossref
Miki Katzir, Tarush Rustagi, Jeffrey Hatef & Ehud Mendel. (2020) Cost Analysis With Use of Expandable Cage or Cement in Single level Thoracic Vertebrectomy in Metastasis. Global Spine Journal 12:5, pages 858-865.
Crossref
Crossref
Priscila Barile Marchi Candido, Fernanda Maris Peria, Altacílio Aparecido Nunes, Rômulo Pedroza Pinheiro, Herton Rodrigo Tavares Costa & Helton L A Defino. (2022) COSTS ANALYSIS OF SPINAL COLUMN METASTASES SURGICAL TREATMENT. Acta Ortopédica Brasileira 30:spe2.
Crossref
Crossref
Roger von Moos, Katie Lewis, Lucy Massey, Andrea Marongiu, Alex Rider & Anouchka Seesaghur. (2022) Initiation of bone-targeted agents in patients with bone metastases and breast or castrate-resistant prostate cancer actively treated in routine clinical practice in Europe. Bone 154, pages 116243.
Crossref
Crossref
Jungho Back, Minh Nam Nguyen, Lu Li, Saelim Lee, Inkyu Lee, Fancheng Chen, Lauren Gillinov, Yeon-Ho Chung, Kareme D. Alder, Hyuk-Kwon Kwon, Kristin E. Yu, Christopher M. Dussik, Zichen Hao, Michael J. Flores, Yoseph Kim, Izuchukwu K. Ibe, Alana M. Munger, Sung Wook Seo & Francis Y. Lee. (2021) Inflammatory conversion of quiescent osteoblasts by metastatic breast cancer cells through pERK1/2 aggravates cancer-induced bone destruction. Bone Research 9:1.
Crossref
Crossref
Chirayu M. Patel, Thaddeus J. Wadas & Yusuke Shiozawa. (2021) Progress in Targeted Alpha-Particle-Emitting Radiopharmaceuticals as Treatments for Prostate Cancer Patients with Bone Metastases. Molecules 26:8, pages 2162.
Crossref
Crossref
Fränce Hardtstock, Zeki Kocaata, Thomas Wilke, Axel Dittmar, Marco Ghiani, Vasily Belozeroff, David J. Harrison, Ulf Maywald & Hans Tesch. (2021) Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are naïve to bone-targeting agents: a comparative analysis of patients with and without skeletal-related events. The European Journal of Health Economics 22:2, pages 243-254.
Crossref
Crossref
Suying Li, Haifeng Guo, Yi Peng, Tingting Gong, Alan Fu, Debajyoti Bhowmik, Rohini K. Hernandez, Katherine B. Carlson, Kimberly A. Lowe, Jitesh Rana & Shuling Li. (2021) Discharge status and post-discharge healthcare costs after skeletal-related event hospitalizations among medicare patients with bone metastatic solid tumors or multiple myeloma. Journal of Bone Oncology 26, pages 100328.
Crossref
Crossref
Sikander Ailawadhi, Rohan Medhekar, Nicole Princic, Robert Fowler, Oth Tran, Debajyoti Bhowmik & Sumeet Panjabi. (2019) Healthcare resource utilization and costs in patients with multiple myeloma with and without skeletal-related events. Journal of Oncology Pharmacy Practice 26:5, pages 1070-1079.
Crossref
Crossref
Roger von Moos, Luis Costa, Eva Gonzalez-Suarez, Evangelos Terpos, Daniela Niepel & Jean–Jacques Body. (2019) Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody. Cancer Treatment Reviews 76, pages 57-67.
Crossref
Crossref
Arif Hussain, Candice Yong, Katherine H. R. Tkaczuk, Yi Qian, Jorge Arellano, C. Daniel Mullins & Eberechukwu Onukwugha. (2018) Prevalence and risk of skeletal complications and use of radiation therapy in elderly women diagnosed with metastatic breast cancer. PLOS ONE 13:3, pages e0193661.
Crossref
Crossref
Naomi Brook, Emily Brook, Arun Dharmarajan, Crispin R. Dass & Arlene Chan. (2018) Breast cancer bone metastases: pathogenesis and therapeutic targets. The International Journal of Biochemistry & Cell Biology 96, pages 63-78.
Crossref
Crossref
C. C. O’Sullivan & Kathryn J. Ruddy. (2016) Management of Potential Long-Term Toxicities in Breast Cancer Patients. Current Breast Cancer Reports 8:4, pages 183-192.
Crossref
Crossref
Michelle E. MeliskoWilliam J. GradisharBeverly Moy. (2016) Issues in Breast Cancer Survivorship: Optimal Care, Bone Health, and Lifestyle Modifications. American Society of Clinical Oncology Educational Book:36, pages e22-e29.
Crossref
Crossref
Sarah Colonna & Theresa L. Werner. 2016. Metastatic Bone Disease. Metastatic Bone Disease
45
54
.
F. Bludau, T. Reis, F. Schneider, S. Clausen, F. Wenz & U. Obertacke. (2015) Kyphoplastie kombiniert mit intraoperativer Radiotherapie (Kypho-IORT)Kyphoplasty combined with intraoperative radiotherapy (Kypho-IORT). Der Radiologe 55:10, pages 859-867.
Crossref
Crossref
Seema SethiAllen Kadado, Anil Sethi & Rahul Vaidya. 2014. miRNAs and Target Genes in Breast Cancer Metastasis. miRNAs and Target Genes in Breast Cancer Metastasis
53
64
.